⌘K

Home/Filings/4/0001209191-21-046561

4//SEC Filing

Allison David D. 4

Accession 0001209191-21-046561

CIK 0001445499other

View on SEC.gov Company Profile

Filed

Jul 12, 8:00 PM ET

Accepted

Jul 13, 5:05 PM ET

Size

5.2 KB

Accession

0001209191-21-046561

Insider Transaction Report

Form 4

Period: 2021-07-11

IMPEL NEUROPHARMA INCIMPL

Allison David D.

Director

Transactions

Award
Stock Option (right to buy)
2021-07-11+11,500→ 11,500 total
Exercise: $9.96Exp: 2031-07-10→ Common Stock (11,500 underlying)

Footnotes (1)

[F1]The option is 100% vested on July 11, 2022.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

IMPEL NEUROPHARMA INC

CIK 0001445499

Entity typeother

Related Parties

1

filerCIK 0001853903

Filing Metadata

Form type: 4
Filed: Jul 12, 8:00 PM ET
Accepted: Jul 13, 5:05 PM ET
Size: 5.2 KB

View on SEC.gov